Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion type Assertion NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_head.
- NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion description "[Moreover, potent pharmacologic inhibitors of MYC or EZH2 suppressed prostate cancer cell growth in vitro, and the knockdown of MST1 caused cells' resistance to MYC and EZH2 inhibitor-induced growth retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_provenance.
- NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion evidence source_evidence_literature NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_provenance.
- NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion SIO_000772 24499724 NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_provenance.
- NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion wasDerivedFrom befree-2016 NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_provenance.
- NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_assertion wasGeneratedBy ECO_0000203 NP1152472.RAC20drwswL4I7fHApLE_Ygf1POQ-2gJt_0RLnqpvwEMU130_provenance.